ACHR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
ACHR is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some long-term thematic upside from eVTOL adoption and certification progress, but the current setup is weak: the trend is bearish, insiders are selling, recent news is negative, and there is no strong proprietary buy signal. If the goal is a direct, impatient entry now, this is a hold rather than a buy.
Current price is 4.979 after a 1.22% regular-session gain, but the broader structure remains weak. MACD histogram is -0.0276 and still below zero, though contracting, which suggests downside momentum is easing but not reversed. RSI_6 is 45.913, neutral and not oversold enough to imply a strong rebound. Moving averages are bearish, with SMA_200 > SMA_20 > SMA_5, confirming a downtrend. Price is sitting just above the pivot at 5.091? Actually the close is below pivot, with S1 at 4.699 as the nearest support and R1 at 5.482 as first resistance. The pattern-based outlook is also soft, with a projected -1.03% move over the next month.
["Archer reached Phase 3 of 4 in the FAA Type Certification process, which is an important de-risking milestone.", "The company still has a growing backlog and the eVTOL market has sizable long-term potential.", "Canaccord maintained a Buy rating despite trimming the price target to $12."]
["Recent news says Archer failed to meet production targets and has competitive disadvantages.", "FY 2025 net loss was $618.2 million, showing very heavy ongoing losses.", "The stock hit a new 52-week low recently, reflecting weak market confidence.", "Insiders are selling and selling volume has increased 117.87% over the last month.", "No recent congress trading data is available.", "No AI Stock Picker or SwingMax signal is present today."]
The latest quarterly financial snapshot was unavailable, but the recent reported FY 2025 result was very weak, with a net loss of $618.2 million. That suggests losses remain large and the company is still in an early, pre-commercial phase. For a long-term investor, the main financial issue is that revenue growth is still not yet translating into profitability or operating scale.
Canaccord lowered its price target to $12 from $13 on 2026-05-12 while keeping a Buy rating after Q1 results. The analyst tone remains constructive on long-term certification progress, but the downward target revision shows reduced near-term confidence. Overall Wall Street pros still see upside potential, but the pros-and-cons balance is mixed: certification and industry optionality are positives, while execution risk, losses, and production issues are the main negatives.
